The National Institutes of Health published a draft biosafety policy on September 14 that would replace its current Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Public comments are open through October 19, 2026.
MPF-Zai Solutions LLC has been obligated $23,761,345 under a delivery order from the Food and Drug Administration for records information management support, according to USAspending.gov contract data.
USAspending.gov records show Leidos Biomedical Research Inc.'s non-competed NIH contract to run the Frederick National Laboratory for Cancer Research has obligated a cumulative $4.81 billion since 2008. The lab's operation is also the subject of a still-unresolved recompete fight.
The Centers for Medicare & Medicaid Services proposed its calendar year 2027 update to the Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center payment system, including a request for information on standardizing hospital price transparency data and a potential separate payment for domestic procurement of PPE and essential medicines. Comments are due August 31, 2026.
The Department of Health and Human Services has obligated $696,665,954 to Phlow Corp. under a contract for domestic advanced manufacturing of active pharmaceutical ingredients, supporting essential medicines and future public health threats.
The Centers for Medicare & Medicaid Services (CMS) published a proposed rule updating Calendar Year 2027 Home Health Prospective Payment System (HH PPS) rates on July 6, 2026. The agency is accepting public comments through August 31, 2026.